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The Zinc-finger factor Insm1 (IA-1)
is essential for the development
of pancreatic  cells and intestinal
endocrine cells
Mathias S. Gierl,1 Nikolaos Karoulias,1 Hagen Wende, Michael Strehle, and Carmen Birchmeier2
Max-Delbrück-Center for Molecular Medicine, Berlin 13125, Germany
The pancreatic and intestinal primordia contain epithelial progenitor cells that generate many cell types.
During development, specific programs of gene expression restrict the developmental potential of such
progenitors and promote their differentiation. The Insm1 (insulinoma-associated 1, IA-1) gene encodes a
Zinc-finger factor that was discovered in an insulinoma cDNA library. We show that pancreatic and intestinal
endocrine cells express Insm1 and require Insm1 for their development. In the pancreas of Insm1 mutant
mice, endocrine precursors are formed, but only few insulin-positive  cells are generated. Instead, endocrine
precursor cells accumulate that express none of the pancreatic hormones. A similar change is observed in the
development of intestine, where endocrine precursor cells are formed but do not differentiate correctly. A
hallmark of endocrine cell differentiation is the accumulation of proteins that participate in secretion and
vesicle transport, and we find many of the corresponding genes to be down-regulated in Insm1 mutant mice.
Insm1 thus controls a gene expression program that comprises hormones and proteins of the secretory
machinery. Our genetic analysis has revealed a key role of Insm1 in differentiation of pancreatic and intestinal
endocrine cells.
[Keywords: Insm1; development; endocrine; intestine; mouse; pancreas]
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Endocrine cells in the pancreas and intestine play key
roles in nutritional homeostasis through the regulated
synthesis and secretion of hormones and growth factors.
The islets of Langerhans contain the four principal en-
docrine cell types of the pancreas, the , , , and PP
cells, which produce the hormones glucagon, insulin, so-
matostatin, and pancreatic polypeptide (PP), respectively
(Edlund 2002; Murtaugh and Melton 2003; Wilson et al.
2003). More recently, a fifth endocrine cell type was
identified that expresses ghrelin (Prado et al. 2004). The
role of  cells is fundamental for energy homeostasis of
the body, and dysfunction or loss of  cells causes dia-
betes. Endocrine cells are also scattered in the epithe-
lium of the intestine and stomach. These endocrine cells
are heterogeneous, and they can be distinguished on the
basis of ultrastructure or content of hormone(s) such as
substance P, secretin, cholecystokinin (CCK), neuroten-
sin, somatostatin, serotonin and peptide YY (PYY) (Rindi
et al. 2004). Interestingly, some basic similarities exist in
the molecular mechanisms that control the develop-
ment of endocrine cells in the intestine and pancreas.
Pancreas development initiates morphologically with
the formation of epithelial buds that protrude dorsally
and ventrally from the foregut (at embryonic day 9.5
[E9.5] in mice) and later fuse to form the definitive pan-
creas. These primordia contain progenitor cells that are
capable of generating all pancreatic cell types, the endo-
crine, exocrine, and duct cells (Gu et al. 2003). Specific
programs of gene expression restrict the developmental
potential of these progenitors and promote their differ-
entiation into the distinct cell types. Significant efforts
have been made to identify the mechanisms that control
the specification and differentiation of pancreatic endo-
crine cells, particularly  cells. Such knowledge may pro-
vide a basis for the generation of insulin-producing cells
from endodermal or embryonic stem (ES) cells (Edlund
2002; Murtaugh and Melton 2003; Wilson et al. 2003).
Mutations in genes encoding components of the Notch
signaling pathway lead to a premature and exclusive dif-
ferentiation of endocrine cells, and Notch signaling is,
thus, essential to maintain the progenitor pool (Apelqvist
et al. 1999; Jensen et al. 2000). The basic helix–loop–
helix (bHLH) transcription factors Ngn3 and NeuroD1
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are essential factors that control the endocrine fate. Mu-
tation of Ngn3 precludes the development of all endo-
crine cells in the pancreas, mutation of NeuroD1 reduces
their number, and the ectopic expression of Ngn3 or
NeuroD1 under the control of the Pdx1 promoter allows
premature and ectopic differentiation of islet cells that
mainly produce glucagon (Naya et al. 1997; Gradwohl et
al. 2000; Schwitzgebel et al. 2000). Thus, these genes
determine an endocrine fate in the pancreas, but the al-
location and differentiation of the different cellular sub-
types appear to be controlled by other genes. Pax4 pro-
motes the specification of the - and -cell fate, and sup-
presses the emergence of  cells. Nkx2.2 and Nkx6.1 are
both essential for -cell differentiation: Nkx2.2 activity
is required to initiate -cell differentiation, while
Nkx6.1 acts downstream from Nkx2.2 (Sosa-Pineda et al.
1997; Sussel et al. 1998; Sander et al. 2000; Wang et al.
2004; Collombat et al. 2005). In addition to their roles in
the early development of the pancreas, Pdx1 (IPF1), Isl1,
Hnf1, Hnf1, Hnf4, or NeuroD1 are also required for
differentiation and maintenance of  cells (Edlund 2002;
Murtaugh and Melton 2003; Wilson et al. 2003). Hetero-
zygous mutations of Pdx1, Hnf1, Hnf1, Hnf4, or
NeuroD1 in humans cause maturity-onset diabetes of
the young (MODY), and further genes that control -cell
development might correspond to susceptibility genes
that contribute to the occurrence of diabetes (Bell and
Polonsky 2001; Shih and Stoffel 2002; Habener et al.
2005).
The intestinal epithelium contains epithelial progeni-
tors that generate endocrine cells, other secretory cells
like goblet and paneth cells, as well as enterocytes.
Notch signaling suppresses the development of intesti-
nal endocrine cells, and mutations in genes that encode
components of the Notch signaling cascade lead to the
appearance of supernumerary entero-endocrine and
other secretory cells (Jensen et al. 2000; Fre et al. 2005;
van Es et al. 2005). The bHLH factor Math1 is an impor-
tant regulator of entero-endocrine development, and mu-
tation of Math1 precludes the differentiation of endo-
crine, goblet, and paneth cells (Yang et al. 2001). Gfi1
controls the allocation of subtypes of secretory cells; in
Gfi1 mutant mice, supernumerary endocrine cells are
formed at the expense of paneth and goblet cells (Shroyer
et al. 2005). Furthermore, Ngn3 is required for the devel-
opment of all endocrine cell types of the intestine,
whereas NeuroD1, Pax4, and Pax6 are necessary for dif-
ferentiation of subtypes of endocrine cells (Naya et al.
1997; Larsson et al. 1998; Jenny et al. 2002; Lee et al.
2002).
The Insulinoma-associated 1 (Insm1, IA-1) gene en-
codes a DNA-binding protein with five Zinc-finger do-
mains and is conserved in evolution (Goto et al. 1992).
The human Insm1 gene was first identified in a subtrac-
tion library from an insulinoma (Goto et al. 1992) and
was subsequently found to be expressed in a large num-
ber of insulinomas and other neuroendocrine tumors, as
well as in the developing pancreas and nervous system
(Goto et al. 1992; Zhu et al. 2002; Breslin et al. 2003).
Available biochemical evidence indicates that expres-
sion of Insm1 is controlled by transcription factors of the
bHLH family, and that Insm1 acts as a transcriptional
repressor (Breslin et al. 2002, 2003). The homologous
genes in Drosophila and Caenorhabditis elegans—ner-
fin-1 and egl-46, respectively—play essential roles in
neuronal development (Wu et al. 2001; Kuzin et al.
2005). The developmental or physiological roles of
Insm1 in vertebrates and the genes controlled by the
factor have not been determined. To characterize the
function of Insm1, we have introduced a targeted muta-
tion in mice. Analysis of the mutant mice demonstrates
that, in Insm1 mutant mice, only few insulin+  cells are
produced. Despite the fact that  cells are generated
eventually in the correct proportion in Insm1 mutant
mice, their differentiation appears to be delayed. In ad-
dition, we provide evidence that the differentiation pro-
gram of pancreatic endocrine cells is not correctly estab-
lished in Insm1 mutant mice, as reflected in the down-
regulation of genes that control hormone processing and
secretion. Furthermore, the differentiation of endocrine
cells of the intestine is impaired in Insm1 mutant mice.
Our analysis indicates that, in the mutant pancreas and
intestine, endocrine precursor cells are generated but are
blocked in their differentiation. Insm1 thus plays a key
role in differentiation of endocrine cells that derive from
the endoderm.
Results
Insm1 is expressed in the endocrine cells
of the pancreas
Insm1 is a single exon gene that is located on mouse
chromosome 2. We introduced a targeted mutation into
the gene by homologous recombination in ES cells. In
the targeting vector, a lacZ cassette was fused in-frame
to the Insm1 initiation codon and Insm1 coding se-
quences were deleted. In addition, the vector contained a
neomycin resistance gene (self-excision neo cassette)
(Bunting et al. 1999) and a sequence encoding fragment A
of diphtheria toxin (DTA) for positive and negative se-
lection in ES cells (Fig. 1A; see also Materials and Meth-
ods). Targeted ES cells were selected, used to generate
chimeras, and transmission of the mutant allele through
the male germline excised the neo cassette (Fig. 1B). In
the resulting Insm1lacZ allele, exogenous sequences
(lacZ and a single loxP site) stay behind to replace the
Insm1 coding sequences, but noncoding Insm1 se-
quences remain intact. Homozygous Insm1lacZ mutant
embryos generated by heterozygous matings were nor-
mal in size and well developed until E12.5. After E12.5,
however, Insm1lacZ/Insm1lacZ embryos were recovered
at frequencies that were lower than the expected Men-
delian ratios and, at birth, Insm1lacZ/Insm1lacZ mice
were apparently unable to breathe and died (for addi-
tional details see Materials and Methods).
Insm1 expression was previously reported in insulin-
expressing pancreatic cell lines (Zhu et al. 2002). In situ
hybridization analysis demonstrated Insm1 expression
in the dorsal pancreatic primordium already at E9.5, and
Gierl et al.
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in the dorsal and ventral primordium at E10.5 (Fig. 1C,D;
Supplementary Fig. 1). In addition, widespread Insm1 ex-
pression was observed in the developing central and pe-
ripheral nervous system. Heterozygous Insm1lacZ em-
bryos were used for a detailed analysis of Insm1 expres-
sion in the developing pancreas. The epithelium of the
dorsal and ventral pancreas is marked by Pdx1, and scat-
tered cells that expressed -galactosidase were present in
the epithelium at E10.75; -galactosidase+ cells also co-
expressed glucagon (Fig. 1E,F). Many -galactosidase+
cells were also Ngn3+, Isl1+, or NeuroD1+, and coexpres-
sion of -galactosidase and insulin or glucagon was also
detectable at E12.5 (Figs. 1G,H, 2). This indicates that
developing endocrine cells express -galactosidase. Ptf1a
marks the exocrine lineage of the pancreas at E12.5
(Krapp et al. 1996), and was not coexpressed with -ga-
lactosidase at E12.5 or subsequent stages (Figs. 1I, 3O).
At E18.5, -galactosidase+ cells that coexpressed insulin,
glucagon, somatostatin, PP, and ghrelin were present in
the pancreas of Insm1lacZ/+ mice (see below). Insm1
transcripts are also present in adult pancreatic islets. Im-
munohistological analysis of adult Insm1lacZ/+ mice in-
dicated that the pancreatic hormones insulin, glucagon,
somatostatin, PP, and ghrelin were coexpressed with
-galactosidase, indicating that all endocrine cell types
maintain Insm1 expression (Fig. 1J; for further details on
Insm1 expression, see Supplementary Fig. 1). The major-
ity of -galactosidase+ cells express a pancreatic hor-
mone at E18.5 (97.6%) and in the adult (99.5%). Thus,
Insm1 expression marks endocrine cells in the develop-
ing and adult pancreas.
Insm1 is essential for the differentiation of pancreatic
endocrine cells
We compared mice heterozygous and homozygous for
the Insm1lacZ allele to assess the function of Insm1 in
the development of endocrine cells of the pancreas. In
situ hybridization with Pdx1 as a probe demonstrated
that the epithelia of the dorsal and ventral pancreatic
buds were similar in size in control and mutant mice at
E12.5. We observed no change in the levels of Pdx1 pro-
tein or in the hybridization intensity at this stage
(Supplementary Fig. 2). At E12.5 or E15.5, numbers of
Figure 1. Generation of the Insm1lacZ
mouse strain and Insm1 expression in the
pancreas. (A) Schematic representation of
the targeting vector, the wild-type Insm1
locus, and the mutated Insm1 allele, be-
fore and after removal of the self-excision
neomycin (cre, neo) cassette. Coding (red)
and noncoding (pink) Insm1 sequences,
NLS-lacZ (blue), DTA, the self-excision
neomycin cassette, loxP (arrowhead), and
StuI (S) restriction sites are depicted. Black
lines indicate the predicted fragment sizes
obtained after StuI digestion of genomic
DNA. A black bar shows the 5 sequence
used as a probe for Southern analyses
shown in B. (B) Southern blot analyses of
StuI-digested genomic DNA from wild-
type, Insm1lacZ/+, and Insm1lacZ/Insm1lacZ
mice. (C,D) In situ hybridization of E9.5
mouse embryos using an Insm1-specific
probe; Insm1 is expressed in the dorsal
pancreatic bud (arrows) and the developing
central and peripheral nervous system.
(E,F) Immunohistological analysis of the
developing pancreas of Insm1lacZ/+ em-
bryos at E10.75 using antibodies against
-galactosidase (red) and Pdx1 (green) (E),
and -galactosidase (red), Pdx1 (green), and
glucagon (blue) (F). (G–I) Immunohisto-
logical analysis of the dorsal pancreas of
Insm1lacZ/+ embryos at E12.5 using anti-
bodies against -galactosidase (red), and
Ngn3 (green) (G), Isl1 (green) (H), and Ptf1a
(green) (I). Coexpression of -galactosidase
with proteins that mark endocrine cells
(Isl1, Ngn3, glucagon) is observed; in con-
trast, Ptf1a is present in exocrine cells and
is not coexpressed with -galactosidase. (J)
Immunohistological analysis of the pancreas of adult Insm1lacZ/+ mice using antibodies against -galactosidase (red) and a mixture of
antibodies directed against insulin, glucagon, PP, somatostatin, and ghrelin (green). Bars: C, 400 µm; D, 50 µm; E,F,J, 20 µm.
Insm1 in endocrine development
GENES & DEVELOPMENT 2467
 Cold Spring Harbor Laboratory Press on April 2, 2014 - Published by genesdev.cshlp.orgDownloaded from 
-galactosidase+ cells in the pancreas were similar, and a
comparable proportion of -galactosidase+ cells coex-
pressed NeuroD1 or Isl1 in heterozygous and homozy-
gous Insm1lacZ mutant mice (Supplementary Figs. 2, 3).
This indicates that early pancreas development and the
generation of the early endocrine precursor cells oc-
curred correctly. However, we found profound changes
in the subsequent differentiation of endocrine cells in
the mutant mice. The first insulin+ cells appear in the
dorsal pancreas and coexpress -galactosidase in
Insm1lacZ/+ mice, and we detected similar numbers of
insulin+ cells in the dorsal pancreas of heterozygous and
homozygous Insm1lacZ mutant mice at E12.5 (Fig. 2A–
C). Many  cells arise during the secondary transition, a
wave of differentiation of endocrine cells that starts
around E13. By E15.5, insulin+ cells are abundant in the
dorsal and ventral pancreas of Insm1lacZ/+ mice, but we
observed only rare insulin+ cells in the dorsal and ventral
pancreas of Insm1lacZ/Insm1lacZ mice (Fig. 2D–F). This
indicates that -cell neogenesis during the secondary
transition does not occur. Glucagon+ cells differentiate
first in the dorsal pancreas, and glucagon+ cells can be
observed in the dorsal pancreas of Insm1lacZ/+ and
Insm1lacZ/Insm1lacZ mice at E12.5. The number of glu-
cagon+ cells was reduced at this stage in Insm1lacZ/
Insm1lacZ mice, and the mutant  cells contained lower
levels of the hormone than the  cells of control mice
(Fig. 2G–I). At E15.5, numbers of glucagon+ cells were
reduced in the dorsal and ventral pancreas of Insm1lacZ/
Insm1lacZ mice, and the mutant  cells contained re-
duced glucagon levels (Fig. 2J–L).
To further assess developing endocrine cells in the
Insm1 mutant mice, we analyzed the expression of tran-
scription factors known to control development and
maintenance of pancreatic endocrine cells. Pdx1 is
known to be essential for the differentiation of  cells
(Ahlgren et al. 1998; Sander et al. 2000; Holland et al.
2002; Fujitani et al. 2006). At E15.5, differentiating 
cells express high levels of Pdx1 protein; Pdx1high cells
coexpress -galactosidase in Insm1lacZ/+ animals. The
number of Pdx1high cells was markedly reduced in the
pancreas of Insm1lacZ/Insm1lacZ mutants. In addition,
Pdx1 is expressed at low levels in many cells of the pan-
creatic epithelium in control mice, and this was not
changed in the Insm1lacZ/Insm1lacZ mutants (Fig. 3A–F).
MafA marks developing  cells (Kataoka et al. 2002; Ol-
brot et al. 2002), and MafA protein was absent in
Insm1lacZ/Insm1lacZ mice (Fig. 3G,H). In addition, the
expression of Nkx2.2, Isl1, and Nkx6.1 was analyzed.
Whereas Nkx2.2 and Isl1 expression was similar in con-
Figure 2. Impaired differentiation of  and  cells in the pancreas of Insm1 mutant mice. Immunohistological analysis of the
developing dorsal pancreas of Insm1lacZ/+ and Insm1lacZ/Insm1lacZ mice at E12.5 (A–C,G–I) and E15.5 (D–F,J–L); the genotypes are
indicated by +/− and −/−, respectively. The antibodies used were directed against -galactosidase (red) and insulin (green) (A,B,D,E), and
-galactosidase (red) and glucagon (green) (G,H,J,K). (C,I) Proportions of -galactosidase+ cells that express insulin (C) and glucagon (I)
in the dorsal pancreas in Insm1lacZ/+ (gray column) and in Insm1lacZ/Insm1lacZ (black column) mice at E12.5. (F,L) Proportions of
-galactosidase+ cells that express insulin (F) or glucagon (L) in the dorsal (D) and ventral (V) pancreas of Insm1lacZ/+ and Insm1lacZ/
Insm1lacZ mice at E15.5. Asterisks indicate p-values of <0.01. Bar, 20 µm.
Gierl et al.
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trol and in Insm1lacZ/Insm1lacZ mice, Nkx6.1 was
down-regulated (Supplementary Fig. 3). We conclude,
therefore, that the expression of Pdx1, Nkx6.1, and MafA
is altered in Insm1 mutant mice, indicating that the loss
of Insm1 affects the transcriptional network that con-
trols -cell differentiation. We further assessed the de-
velopment of the -cell lineage in the Insm1lacZ mutant
mice. MafB is expressed in developing  cells of control
mice (Artner et al. 2006) and was markedly reduced in
the Insm1lacZ/Insm1lacZ mice (Fig. 3I–N). Arx and Pax6
are expressed in  cells and are important determinants
in the development of this lineage (St-Onge et al. 1997;
Collombat et al. 2003). Arx and Pax6 expression was also
reduced (Table 1; Supplementary Fig. 3). Thus, the tran-
scriptional network that controls -cell differentiation is
also changed in the pancreas of Insm1 mutant mice. In
contrast, the exocrine lineage, as assessed by histology
and immunohistological analysis of Ptf1a and amylase
expression, appeared unchanged in Insm1 mutant mice
(Figs. 3O,P, 4A,B; Supplementary Fig. 4). We conclude,
therefore, that the Insm1 mutation causes major deficits
in the differentiation of pancreatic endocrine cells, but
does not impair the exocrine lineage.
Histological analysis at E18.5 demonstrated the pres-
ence of islets of Langerhans in the pancreas of heterozy-
gous and homozygous Insm1lacZ mutant mice. The is-
lets in the Insm1lacZ/Insm1lacZ mice, however, dis-
played an increased density of nuclei compared with
control animals (Fig. 4A,B). We also counted the overall
number of -galactosidase+ endocrine cells in the pan-
creas, and observed a 26% reduction at E18.5 in the mu-
tant mice and no significant differences at E15.5
(599 ± 48 cells per section and 444 ± 47 cells per section
in heterozygous and homozygous Insm1lacZ mice at
E18.5, respectively; p-value: 0.0079, n = 3 pancreata;
355 ± 82 cells per section and 281 ± 69 cells per section
in heterozygous and homozygous Insm1lacZ mice at
E15.5, respectively; p-value: 0.11, n = 4 pancreata). Apo-
ptosis at late developmental stages appears to account
for the reduced cell number, since TUNEL+ cells in the
pancreas at E18.5 were more abundant in homozygous
than in heterozygous Insm1lacZ mutant mice (Supple-
mentary Fig. 4). We counted the proportion of -galacto-
sidase+ cells that coexpressed insulin and observed a
92% reduction in the number of  cells in Insm1lacZ/
Insm1lacZ mice at E18.5 (Fig. 4C–E). The proportion of
-galactosidase+ cells that coexpressed somatostatin was
also reduced in Insm1lacZ/Insm1lacZ mice (Fig. 4F). The
proportion of glucagon+ cells was similar in Insm1lacZ/+
and Insm1lacZ/Insm1lacZ mice (Fig. 4G–I). However, mu-
tant  cells contained less glucagon protein as assessed
by the intensity of the immunohistological staining, and
glucagon mRNA was down-regulated (Table 1). A de-
layed accumulation of glucagon protein might thus ac-
count for the reduction in the number of glucagon+ cells
observed at earlier stages. Thus, despite the fact that glu-
cagon+ cells are produced in the correct proportion, their
differentiation appears to be impaired. The proportions
of -galactosidase+ cells that coexpressed PP or ghrelin
were elevated and reduced, respectively, and the propor-
Table 1. Comparison of gene expression in the pancreas of
heterozygous and homozygous Insm1lacZ mutant mice
Symbol Gene name
Fold
change
Change
p-value
Hormones
Ins1 Insulin I −13.1 **
Ins2 Insulin II −13.5 **
Gcg Glucagon −4.1 **
Ppy PP p, nc ns
Ghrl Ghrelin p, nc ns
Sst Somatostatin −2.5 **
Npy Neuropeptide Y −8.3 **
Glucose metabolism
Slc2a2 Glut2 −2.9 **
G6pc2 Glucose-6-phosphatase, islet
specific −19.4 **
Hormone processing and secretion
Pcsk1 Prohormone convertase 1/3 −2.6 **
Pcsk2 Prohormone convertase 2 −2.8 **
Chga Chromogranin A −24.9 **
Chgb Chromogranin B −40.0 **
Nnat Neuronatin −7.2 **
Resp18 Regulated endocrine-specific protein 18 −11.8 **
Rph3al Rabphilin 3A-like −2.1 **
Scg2 Secretogranin II −33.3 **
Scg3 Secretogranin III −16.6 **
Scgn Secretagogin −13.6 **
Sgne1 Secretogranin V −9.3 **
Snx5 Sorting Nexin 5 −2.5 **
Sytl4 Synaptotagmin-like 4 −4.4 **
Transcription factors
Nkx2-2 Nkx2.2 p, nc ns
Nkx6-1 Nkx6.1 −1.6 *
Pax4 Pax4 p, nc ns
Pax6 Pax6 −2.4 **
Ipf1 Pdx1 −1.3 *
MafB MafB −1.9 **
Arx Arx a —
Adhesion
Cdh2 Ncad p, nc ns
Others
Iapp Islet amyloid polypeptide −2.1 **
Aplp1 Amyloid  precursor-like protein 1 −3.1 **
Gch1 GTP cyclohydrolase −2.7 **
Gja9 Connexin 36 −6.6 **
Gng4 GTP-binding protein  4 subunit −4.9 **
Sez6l2 Seizure-related 6 homolog-like 2 −26.5 **
Slc30a8 Solute carrier family 30 member 8 −5.3 **
Systematic analysis of gene expression in control and Insm1−/−
mice using Affymetrix oligonucleotide microarrays. The aver-
age signal fold change and the change p-value as calculated by
Affymetrix MAS 5.0 software are shown. Genes were selected
based on a consistent and significant differential expression at
E15.5 and E18.5. We also display data for those genes that were
analyzed in this study by immunohistological analysis, in situ
hybridization, or RT–PCR. Genes whose expression was ana-
lyzed by microarray analysis and by additional techniques are
marked in bold. Genes whose expression was changed with a
p-value 0.05 and 0.001 are marked by single or double aster-
isks, respectively. No probe sets exist for MafA on the MOE 430
2.0 GeneChip. (p) Present; (a) absent; (nc) not changed; (ns) not
significant.
Gierl et al.
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tion of ghrelin+/glucagon− cells was unchanged (Fig. 4J–
N). It should be noted that the numbers of , PP, or 
cells remained small in the islets of Insm1 mutant mice,
indicating that transdifferentiation of the mutant  cells
into one of these endocrine cell types did not occur.
In Insm1lacZ/+ mice, the majority of -galactosidase+
islet cells express one of the pancreatic hormones at
E18.5. This was, however, not observable in Insm1lacZ/
Insm1lacZ mice, where many -galactosidase+ cells were
present that expressed neither insulin, glucagon, so-
matostatin, PP, nor ghrelin (Fig. 4O–Q). Thus, other hor-
mone-producing cell types do not form at the expense of
 cells in Insm1lacZ/Insm1lacZ mice, indicating that 
cells arrest their differentiation. We investigated if other
proteins typically present in endocrine cells were ex-
pressed correctly in Insm1lacZ/Insm1lacZ mice. The glu-
cose transporter 2 (Glut2) and the islet amyloid polypep-
tide (IAPP) are expressed in  cells of control mice at
E18.5. Cells that expressed Glut2 were rare in Insm1lacZ/
Insm1lacZ mice, but many cells remained that expressed
low levels of IAPP (Fig. 4R–T; Supplementary Fig. 4).
Furthermore, the prohormone convertase 1/3 as well as
chromogranin A, which are expressed broadly in the pan-
creatic endocrine cell types, were significantly down-
regulated in the mutant mice. We analyzed the expres-
sion of these differentiation markers, specifically in glu-
cagon+ cells, and found them down-regulated. Thus,
mutant  cells expressed not only glucagon at lower lev-
els, but also other differentiation markers like the pro-
hormone convertase 2 and chromogranin A. In addition,
changes in gene expression were also analyzed system-
atically using microarray analysis (Table 1). This indi-
cated changes in transcript levels of pancreatic hor-
mones, prohormone convertases, IAPP, and chromogra-
nin A in the Insm1 mutant mice, and thus verified the
reduced levels of the corresponding proteins observed by
immunohistological analysis. Interestingly, this system-
atic analysis revealed an additional set of significantly
down-regulated transcripts, whose protein products
function in vesicle transport and secretion—for instance,
chromogranin B; secretogranin II, III, and V; sorting
nexin 5; and synaptogamin-like protein 4. We conclude,
therefore, that terminal differentiation of pancreatic en-
Figure 4. Islet histology and hormone expression in the pan-
creas of Insm1 mutant mice. Histological and immunohisto-
logical analyses of the developing pancreas of Insm1lacZ/+ and
Insm1lacZ/Insm1lacZ mice at E18.5; the genotypes are indicated
by +/− and −/−, respectively. (A,B) Hematoxylin/eosin (HE)
staining of semi-thin sections of the pancreas. Islets are present
in Insm1lacZ/Insm1lacZ mice but display a changed nuclear den-
sity. Immunohistological analysis of the pancreas using anti-
bodies directed against -galactosidase (shown in red). In addi-
tion, antibodies directed against insulin (blue) and somatostatin
(green) (C,D), glucagon (blue) and PP (green) (G,H), and ghrelin
(green) (K,L) were used. (O,P) Immunohistology using rabbit
anti-insulin, rabbit anti-glucagon, rabbit anti-somatostatin, rab-
bit anti-PP, and rabbit anti-ghrelin (green), and goat anti--ga-
lactosidase (red) antibodies simultaneously. Note that many
-galactosidase+ cells exist in the pancreas of Insm1lacZ/
Insm1lacZ embryos that do not express any of these five hor-
mones. (R,S) Immunohistological analysis of the pancreas using
antibodies against -galactosidase (shown in red) and IAPP
(green). The proportions of the -galactosidase+ cells that ex-
press insulin (E), somatostatin (F), glucagon (I), PP (J), ghrelin
(M), ghrelin but not glucagon (N), any of the five hormones (Q),
or IAPP (T) are displayed. Single and double asterisks indicate
p-values of <0.01 and <0.001, respectively. Bars, 20 µm.
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docrine cells is impaired in Insm1 mutant mice, as re-
flected in a reduced expression of many genes involved
in hormone secretion.
Insm1 is essential for the differentiation of endocrine
cells in the intestine
Insm1 expression can also be detected in the intestine. In
Insm1lacZ/+ animals, -galactosidase+ cells are scattered
in the intestinal epithelium and many of these coexpress
NeuroD1 at E15.5 (arrows in Fig. 5A,B) or at E18.5
(Supplementary Fig. 5). Thus, these cells in the epithe-
lium correspond to developing entero-endocrine cells.
Additional -galactosidase+ cells are observed in a ring of
cells located in the enteric mesenchyme (arrowhead in
Fig. 5A); the distribution of these indicates that they cor-
respond to the developing enteric nervous system. Chro-
mogranin A identifies the majority of entero-endocrine
cells (Rindi et al. 2004), and many -galactosidase+ cells
in the intestinal epithelium of Insm1lacZ/+ animals co-
expressed chromogranin A (Fig. 5C). Similarly, synapto-
physin that marks entero-endocrine cells (Rindi et al.
2004; Sancho et al. 2004) is coexpressed with -galacto-
sidase in the intestinal epithelium (Fig. 5D). Mucin 2 or
lysozyme, which mark paneth and goblet cells, respec-
tively (Sancho et al. 2004), were however not coex-
pressed with -galactosidase (Fig. 5E,F). Expression of
Insm1 persists in the adult intestine (Supplementary Fig.
1). We conclude that Insm1 is expressed in developing
endocrine cells of the intestine.
We compared the development of endocrine cells in
the intestine of mice heterozygous and homozygous for
the Insm1lacZ allele. We observed no obvious difference
in the overall number of -galactosidase+ cells in the intes-
tinal epithelium of Insm1lacZ/+ and Insm1lacZ/Insm1lacZ
mice at E15.5 or E18.5 (Fig. 6). At E15.5 or E18.5, the
proportion of -galactosidase+ cells in the intestinal epi-
thelium that coexpressed NeuroD1 was similar in het-
erozygous and homozygous Insm1lacZ mutant mice; ex-
pression of Ngn3, as assessed by in situ hybridization,
was not affected (Supplementary Fig. 5). This indicates
that endocrine precursor cells are formed correctly in
Insm1lacZ mutant mice, but further analysis showed
that their differentiation was altered. For instance, the
number of cells that expressed chromogranin A was se-
verely reduced and synaptophysin+ cells were absent in
the intestine of Insm1lacZ/Insm1lacZ animals (Fig. 6A–C;
data not shown). Subtypes of entero-endocrine cells ex-
press a particular hormone, and subtypes that coexpress
more than one hormone exist. Neurotensin is expressed
by 30% of -galactosidase+ cells in the epithelium of the
small intestine in Insm1lacZ/+ mice at E18.5. However,
neurotensin+ cells were not observed in Insm1lacZ/
Insm1lacZ animals (Fig. 6D–F). Similarly, substance P is
expressed by 40% of -galactosidase+ cells in the intes-
tinal epithelium of Insm1lacZ/+ animals, and was not
present in the Insm1lacZ/Insm1lacZ mice. The propor-
tions of cells that coexpressed serotonin and -galacto-
sidase, or CCK and -galactosidase, were reduced in the
Insm1lacZ/Insm1lacZ mice (Fig. 6J–O), and fewer PYY+
cells were observed (data not shown). In contrast, the
proportion of -galactosidase+ cells that express secretin
was similar in heterozygous and homozygous Insm1lacZ
mutant mice (Fig. 6P–R). Alcian blue and periodic acid-
Schiff stainings indicated that paneth and goblet cells
were produced correctly (Supplementary Fig. 5). We con-
clude, therefore, that Insm1 is essential for the expres-
sion of secretory vesicle proteins (chromogranin A, syn-
aptophysin) in entero-endocrine cells. In addition, Insm1
is required for the differentiation of particular subtypes
of intestinal endocrine cells, which are either absent
(substance P+ or neurotensin+ cells) or formed in reduced
numbers (serotonin+, CCK+, or PYY+ cells) in Insm1 mu-
tant mice.
Figure 5. Insm1 expression in the developing intestine. Immu-
nohistological analysis of the developing intestine of
Insm1lacZ/+ mice at E15.5 (A,B) and E18.5 (C–F). (A) -Galacto-
sidase (red) was observed in the intestinal epithelium (arrow)
and the enteric nervous system (arrowhead) of Insm1lacZ/+
mice. (B) -Galactosidase (red) is coexpressed with NeuroD1
(green) in entero-endocrine cells located in the intestinal epi-
thelium (arrows), but not in the enteric nervous system (arrow-
head); coexpressing cells appear yellow, an overlap of the red
and green fluorescence. In the intestinal epithelium, all cells
that contained chromogranin A (CA, green) (C) or synaptophy-
sin (Syp, green) (D) coexpressed -galactosidase. In contrast, Mu-
cin2 (Muc2, green) (E) or lysozyme (green) (F) proteins were not
observed in the -galactosidase+ (red) cells. Sections were coun-
terstained with TOTO-3 (blue). Bars: A, 50 µm; C, 20 µm.
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Discussion
Insm1, a gene encoding a Zn-finger transcription factor,
is expressed in endocrine cells of the pancreas and intes-
tine. Our genetic analysis demonstrates the essential
function of Insm1 in the differentiation of pancreatic and
intestinal endocrine cells. We show that, in the pancreas,
 cells are severely impaired in their differentiation. 
Cells eventually form in a correct proportion, but their
appearance is delayed and they express low levels of glu-
cagon. Furthermore, intestinal endocrine cells do not de-
velop correctly in Insm1 mutant mice. We observed a
25-fold reduction in the numbers of chromogranin A+
cells, and particular subtypes of intestinal endocrine
cells are absent or reduced in number. Notch signals and
the transcription factors Ngn3, NeuroD1, Pax4, and Pax6
have previously been shown to control the development
of endocrine cells in both, the pancreas and intestine,
demonstrating that an overlapping set of genes directs
the developmental program of these endodermal-derived
endocrine lineages (Schonhoff et al. 2004; Habener et al.
2005). The phenotypes that we observed indicate that
Insm1 determines particular aspects of the differentia-
tion program of endocrine cells and acts downstream
from Notch and Ngn3, which promote an endocrine fate.
The function of Insm1 in development
of the endocrine pancreas
The mature pancreas contains endocrine, exocrine, and
ductal cells, which develop from a single progenitor cell
type (Gu et al. 2003). A number of genes have been iden-
tified that specifically control the development of the
endocrine lineage. Among those, Ngn3 promotes an en-
docrine fate, Pax4 and Arx determine whether an endo-
crine progenitor cell adopts an - or -cell fate, whereas
Nkx2.2 and Nkx6.1 control the differentiation of pancre-
atic  cells (Sussel et al. 1998; Gradwohl et al. 2000;
Sander et al. 2000; Schwitzgebel et al. 2000; Prado et al.
2004). In addition to its early function in the develop-
ment of the pancreas, Pdx1 is also essential for -cell
differentiation (Jonsson et al. 1994; Stoffers et al. 1997;
Fujitani et al. 2006). Here we identified a novel factor,
Insm1, to be essential for the development of the pan-
creatic -cell lineage. The Insm1 gene was previously
shown to be expressed in insulinomas, other endocrine
tumors, and the pancreas (Goto et al. 1992; Zhu et al.
2002), but the function of this Zn-finger factor had not
been assessed. Our genetic analysis using Insm1 mutant
mice demonstrates that Insm1 is indispensable for the
correct differentiation of the -cell lineage. In Insm1 mu-
tant mice, many -cell precursors appear to be main-
tained, but these do not express any of the pancreatic
hormones. This phenotype is not identical to the one
observed in Nkx2.2, Pax4, and Nkx6.1 mutant mice: In
Nkx2.2 or Pax4 mutant mice, ghrelin-expressing cells
replace  cells, whereas in Nkx6.1 mutants, -cell neo-
genesis is defective, but undifferentiated endocrine cells
do not accumulate (Sander et al. 2000; Prado et al. 2004).
Immunohistological and microarray analyses reveal a
Figure 6. Insm1 is essential for the differentiation of entero-
endocrine cells. Immunohistological analysis of the intestine of
Insm1lacZ/+ and Insm1lacZ/Insm1lacZ mice at E18.5, using anti-
bodies directed against chromogranin A (A,B), neurotensin
(D,E), substance P (G,H), serotonin (J,K), CCK (M,N), and secre-
tin (P,Q) (all shown in green); in addition, antibodies against
-galactosidase (shown in red) were used. The proportion of
-galactosidase+ cells that express chromogranin A (C), neuro-
tensin (F), substance P (I), serotonin (L), CCK (O), and secretin
(R) are displayed. Sections were counterstained with TOTO-3
(blue). Single and double asterisks indicate p-values of <0.005
and <0.0001, respectively. Bar, 20 µm.
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down-regulation of Nkx6.1 and Pdx1 in the pancreas of
Insm1 mutant mice, indicating that Insm1 affects the
transcriptional network that determines -cell differen-
tiation.
In the Insm1lacZ mutant allele, Insm1 coding se-
quences were replaced by lacZ. This allowed us to follow
cells that express the allele in heterozygous and homo-
zygous mutant mice. Our analysis indicates that Insm1
is expressed in all endocrine cell types of developing and
adult pancreatic islets; i.e., in , , PP, , and  cells. In
Insm1 mutant mice, endocrine precursor cells were gen-
erated, as assessed by the expression of Isl1, NeuroD1,
and Ngn3, but their differentiation was impaired. The
development of  cells was most severely affected. In
particular, we noted a massive reduction in the number
of insulin+ cells in Insm1 mutant mice, and many pro-
teins present in  cells of control mice (Glut2, IAPP,
prohormone convertase 1/3, chromogranin A) were
strongly down-regulated. Furthermore, we did not ob-
serve an up-regulation of genes that would be indicative
of a transdifferentiation of cells in the mutant pancreas
and, in particular, other pancreatic endocrine cell types
did not replace the mutant  cells. The mutant  cells
retained, however, the expression of -galactosidase and
some expressed also IAPP at low levels, indicating that
they keep the character of pancreatic endocrine cells,
and we propose that they are arrested in their terminal
differentiation. In addition, we observed changes in the
proportions of endocrine cells that express somatostatin
or PP in Insm1lacZ mutant mice. Lineage analysis has
indicated that , , and PP cells derive from a common
lineage (Herrera et al. 1994; Herrera 2000). Our data in-
dicate, therefore, that the molecular networks that en-
sure that these endocrine cell types are formed in correct
proportion are also affected by the Insm1 mutation.
Not only  cells require Insm1 for differentiation; we
also observed significant changes in the development of
the -cell lineage. Analysis of the numbers of glucagon+
cells indicated that they were initially reduced (E12.5,
E15.5), but eventually these cells were present in correct
proportion (E18.5), indicating that the effects of Insm1
on early and late  cells might be distinct. Nevertheless,
the expression levels of glucagon in the mutant  cells
remained low. Furthermore, other proteins (prohormone
convertases 1/3 and 2, chromogranin A) that are ex-
pressed in many pancreatic endocrine cell types and are
present in  and  cells were markedly down-regulated
in Insm1 mutant mice. Thus, despite the fact that  cells
form in a correct proportion, their terminal differentia-
tion is impaired. By microarray analysis, we found addi-
tional genes that function in hormone maturation, se-
cretion, and vesicle transport to be down-regulated in the
pancreas of Insm1 mutant mice, indicating that Insm1
controls a genetic program that allows pancreatic hor-
mone production and secretion. It is possible that the
expression of some of these genes is altered not only in 
and  cells, but also in the other subtypes of pancreatic
endocrine cells. Available biochemical evidence indi-
cates that Insm1 acts as a transcriptional repressor.
Members of the snail family of Zn-finger transcription
factors are related to Insm1, display a similar overall do-
main structure—i.e., a “SNAG” domain and five Zn-fin-
gers—and are known to act as transcriptional repressors
(Grimes et al. 1996). However, in our microarray analy-
sis, genes that were significantly and consistently up-
regulated at E15.5 and E18.5 were not observed in the
mutant mice, raising the possibility that Insm1 might
also function as a transcriptional activator. It is notewor-
thy that immunohistological analysis had revealed aber-
rantly high levels of N-cadherin in pancreatic islets of
Insm1 mutant mice (Supplementary Fig. 4), but micro-
array analysis indicated no significant change in the
level of the corresponding transcript. Changes in the
turnover of N-cadherin protein might be responsible for
this and could contribute to the altered islet morphology
in Insm1 mutant mice.
The function of Insm1 in the development
of intestinal endocrine cells
Our analysis of Insm1 mutant mice demonstrates that
this factor is essential not only for development of pan-
creatic endocrine cells, but also for the differentiation of
endocrine cells of the intestine. The intestinal epithe-
lium contains secretory cells (endocrine, paneth, and
goblet cells) and absorptive enterocytes, which all derive
from multipotent epithelial stem cells (Cohn et al. 1991).
This stem cell does not appear to produce directly intes-
tinal endocrine cells but generates a series of intermedi-
ary cells that become further restricted in their develop-
mental potential. Available evidence indicates that a
committed progenitor exists that gives rise to all secre-
tory cell types (Yang et al. 2001). This progenitor pro-
duces cells that generate either the paneth/goblet or the
endocrine lineage (Shroyer et al. 2005). The endocrine
precursor expresses Ngn3 and requires Ngn3 for its for-
mation, whereas NeuroD1 functions downstream from
Ngn3 to coordinate cell cycle exit and terminal differen-
tiation (Mutoh et al. 1998; Jenny et al. 2002). Using the
Insm1lacZ allele, we demonstrate here that Insm1 is ex-
pressed in developing intestinal endocrine cells. The ex-
tensive coexpression of -galactosidase and NeuroD1 at
E15.5 indicates that Insm1 is expressed mainly in post-
mitotic cells destined to form the entero-endocrine lin-
eage. Differentiated entero-endocrine cell types express
chromogranin A and synaptophysin (Rindi et al. 2004;
Sancho et al. 2004). -Galactosidase is coexpressed with
chromogranin A and synaptophysin in heterozygous
Insm1lacZ animals, and the proportion of coexpressing
cells increases as development proceeds. This indicates
that -galactosidase expression initiates prior to the dif-
ferentiation of entero-endocrine cells and persists in the
differentiating cells. In homozygous Insm1lacZ mutant
mice, -galactosidase+ cells form in the intestinal epi-
thelium and coexpress NeuroD1, demonstrating that en-
tero-endocrine precursor cells are generated. However,
the Insm1 mutation affected their further differentia-
tion; i.e., the expression of hormones and of secretory
vesicle proteins like chromogranin A and synaptophysin.
Interestingly, chromogranin A expression was down-
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regulated in intestinal and pancreatic endocrine cells of
Insm1 mutant mice, indicating that similarities in the
gene expression program controlled by Insm1 might ex-
ist in these two organs. We conclude that Insm1 controls
endocrine differentiation in the intestine and pancreas
and acts downstream from Notch and Ngn3 that specify
the endocrine fate in both organs.
Insm1 and pancreatic  cells
Impaired function or loss of pancreatic  cells cause dia-
betes, a prevalent human disease throughout the world.
We demonstrate here that -cell differentiation is ar-
rested in Insm1 mutant mice. Insm1 mutant mice ap-
pear unable to breathe and die at birth, indicating that
other, as-yet-uncharacterized phenotypes are present in
these mice. The postnatal lethality has precluded the
analysis of the consequences of the Insm1 mutation on
nutritional homeostasis. Many genes that contribute to
the occurrence of diabetes encode transcription factors
that play key roles in development of pancreatic  cells
(Bell and Polonsky 2001; Shih and Stoffel 2002; Habener
et al. 2005). Further studies are required to assess
whether Insm1, beyond its role in -cell differentiation,
is also essential for the maintenance and the correct
function of  cells.
While this manuscript was under review, a study on
Insm1 expression and function appeared in press (Mel-
litzer et al. 2006). This paper demonstrates that Insm1 is
not expressed in Ngn3 mutant mice, and provides evi-
dence that Insm1 is a direct target gene regulated by
Ngn3. Furthermore, after application of Insm1 morpho-
linos to cultured pancreatic tissue, the authors report a
reduction in numbers of developing insulin+ and gluca-
gon+ cells, confirming, thus, our data obtained in geneti-
cally modified mice.
Materials and methods
Generation of Insm1-null mice
The 129/Sv mouse PAC clone RPCIP711L1640Q2 (Resource
Center/Primary Database, http://www.rzpd.de) containing
Insm1 was isolated from the RPCI-21 library (Osoegawa et al.
2000). A 14-kb DNA fragment containing the Insm1 gene was
isolated by gap repair (Lee et al. 2001). Homologous recombina-
tion in bacteria (Lee et al. 2001) was used to fuse an NLS-lacZ
cassette to the ATG of Insm1, to introduce the self-excision neo
cassette (Bunting et al. 1999), and to delete the coding sequence
of Insm1. In addition, the MC1-diphtheria toxin A (DTA) cas-
sette was placed at the 5 end of the vector and was used for
negative selection. E14.1 ES cells (129/Ola) were electroporated,
and colonies that had incorporated the targeting vector into
their genome were selected by G418 and analyzed for homolo-
gous recombination by Southern blot analysis using 5 and 3
sequences that lie outside of the targeting vector, as well as lacZ
sequences as probes. We injected blastocysts and identified chi-
meras that transmitted the mutant Insm1lacZ gene by mating
chimeras to C57BL/6 females. The mutant strain was subse-
quently expanded by mating Insm1lacZ males to C57BL/6 fe-
males. Routine genotyping was performed by PCR and, occa-
sionally, genotypes were verified by Southern blot hybridiza-
tion. Lines deriving from two independently targeted ES cells
were established. One line was used for the characterization of
Insm1 function, and the other for verification of the phenotype.
Embryos derived from heterozygous matings were isolated at
different stages of development. Insm1lacZ/Insm1lacZ embryos
were observed at the expected Mendelian frequency at E12.5
and earlier stages, but were recovered at lower ratios subse-
quently. At E18.5, only four out of 76 mice (5.2%) generated by
heterozygous matings had an Insm1lacZ/Insm1lacZ genotype, in-
dicating that the majority of Insm1lacZ/Insm1lacZ embryos died
during the second half of gestation on the mixed 129/Ola and
C57BL/6 genetic background. Surviving Insm1lacZ/Insm1lacZ
mice on the 129/Ola and C57BL/6 background were apparently
well developed and normal in size at E18.5. The Insm1lacZ allele
was then crossed for two to three generations onto the CD1
out-bred strain. On such a mixed genetic background, the le-
thality was reduced, and 60 out of 451 (13%) mice generated by
heterozygous matings had an Insm1lacZ/Insm1lacZ genotype at
E18.5. Again, the surviving mice were apparently well devel-
oped and normal in size. We used animals of a mix of the CD1,
129/Ola, and C57BL/6 background to generate the homozygous
mice used for the analysis presented here. In addition, we also
compared the pancreas of Insm1lacZ/Insm1lacZ and Insm1lacZ/+
mice on the mixed 129/Ola and C57BL/6 background, and ob-
served very few  cells and a comparable number of  cells at
E18.5 (see Supplementary Fig. 4). Regardless of the genetic back-
ground, homozygous Insm1lacZ mice remained cyanotic—i.e.,
appeared to be unable to breathe—and died shortly after birth.
In situ hybridization, histology, and immunohistology
In situ hybridization and histological analysis of mouse em-
bryos were performed as previously described (Britsch et al.
1998). A 510-base-pair (bp) fragment located in the 3 untrans-
lated region (UTR) of the mouse Insm1 gene was used to gen-
erate the RNA probe. For immunohistological analysis, tissue
was dissected and fixed with 4% paraformaldehyde in phos-
phate buffer (pH 7.4) for 2 h. Intestinal tissues were flushed
gently with PBS prior to fixation. Antibody staining was per-
formed on 10- to 12-µm cryosections, using the following anti-
bodies: goat anti--galactosidase (1:1000; Biogenesis), rabbit
anti--galactosidase (1:10,000; ICN Biochemical), rabbit anti-
glucagon (1:1000; ImmunoStar), guinea pig anti-glucagon (1:500;
Linco), rabbit anti-insulin (1:1000; ImmunoStar), guinea pig
anti-insulin (1:1000; Biogenesis), rabbit anti-PP (1:500; Chemi-
con), rabbit anti-somatostatin (1:500; DakoCytomation), rabbit
anti-Pdx1 (1:500; Chemicon), goat anti-NeuroD1 (1:500; Santa
Cruz), guinea pig anti-Isl1 (1:20,000; a gift from Tom Jessell,
Columbia University, New York), guinea pig anti-NKX6.1
(1:500; a gift from Maike Sander, University of California at
Irvine, Irvine, CA), rabbit anti-Arx (1:500; a gift from Ahmed
Mansouri, Max Planck Institute for Biophysical Chemistry,
Göttingen, Germany), guinea pig anti-MafA (1:20,000), rabbit
anti-Ptf1a (1:500; a gift from Helena Edlund, University of
Umea, Umea, Sweden), rabbit anti-secretin (1:50; Abcam), rab-
bit anti-neurotensin (1:3000; Sigma), rabbit anti-lysozyme
(1:500; DakoCytomation), rabbit anti-CCK (1:250; Biotrend),
rabbit anti-PYY (1:6000; Biotrend), rabbit anti-chromogranin A
(1:1000; ImmunoStar), rabbit anti-synaptophysin (Zymed), rab-
bit anti-serotonin (1:5000; Sigma), rabbit anti-substance P
(1:1000; Zymed), rabbit anti-mucin 2 (1:5000; Santa Cruz Bio-
technology), rabbit anti-neurogenin3 (1:2000; a gift from Mi-
chael German, University of California at San Francisco, San
Francisco, CA), guinea pig anti-MafB (1:20,000), rabbit anti-gh-
relin (1:2000; a gift from Cathrine Tomasetto, Institut National
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de la Santé et de la Recherche Médicale [INSERM], Strasbourg,
France), goat anti-ghrelin (1:1000; Santa Cruz Biotechnology),
rabbit anti-IAPP (1:1000; Progen), guinea pig anti-Nkx2.2
(1:4000; a gift from Beatriz Sosa-Pineda, St. Jude’s Children’s
Hospital, Memphis, TN), rabbit anti-prohormone convertase
1/3 (1:100; Chemicon), rabbit anti-prohormone convertase 2
(1:100; Chemicon), goat anti-Glut2 (1:1000; Santa Cruz Biotech-
nology), rabbit anti-N-Cadherin (1:100; Santa Cruz Biotechnol-
ogy), rabbit anti-amylase (1:100; Santa Cruz Biotechnology), and
secondary antibodies conjugated with Cy2, Cy3, or Cy5 (Jack-
son ImmunoResearch). Intestinal sections were counterstained
with the nuclear dye TOTO-3 (1:10,000; Molecular Probes). Cell
death was determined by TUNEL staining using an Apop-Tag
fluorescein in situ apoptosis detection kit (Intergen). Fluores-
cence was imaged on a Zeiss LSM 5 Pascal confocal microscope,
and images were processed in Adobe Photoshop.
Cell counts
To determine the proportion of -galactosidase+ cells that ex-
press a particular pancreatic hormone, we used images taken
from sections that were stained for -galactosidase as well as for
one of the hormones (insulin, glucagon, somatostatin, PP, or
ghrelin). Cells that expressed -galactosidase and a particular
hormone were counted on at least three sections obtained from
three to four independent heterozygous and homozygous
Insm1lacZ mice. To determine the proportion of -galactosi-
dase+ cells that coexpress each of the hormones, at least 300
-galactosidase+ cells were analyzed at E15.5 and E18.5, and at
least 100 -galactosidase+ cells were analyzed at E12.5. The
overall number of -galactosidase+ cells was essentially deter-
mined as described (Collombat et al. 2005). The absolute num-
bers of -galactosidase+ cells and the proportion of hormone+
cells can be used to calculate the absolute numbers of the cells
that express a particular hormone. A comparison of the calcu-
lated absolute numbers—for instance, of  and  cells—shows a
pronounced reduction of  cells and similar numbers of  cells
when heterozygous and homozygous Insm1lacZ mice were com-
pared.
In the intestine, cells that coexpress -galactosidase and vari-
ous markers of endocrine cells were counted from sections ob-
tained from three to four independent heterozygous and homo-
zygous Insm1lacZ mice. To determine the proportion of -galac-
tosidase+ cells that coexpress hormones/proteins, at least 100
-galactosidase+ cells were analyzed. To determine the signifi-
cance of the observed differences, a Student’s t-test for a one-
tailed distribution and a two-sample unequal variance was ap-
plied.
Microarray analysis
Whole pancreata were collected in RNAlater (Ambion) from
E15.5 and E18.5 wild-type and Insm1lacZ/Insm1lacZ embryos
and homogenized in Trizol (Invitrogen). RNA extraction, probe
synthesis, and hybridization to Affymetrix MOE430 2.0 micro-
arrays (Affymetrix) were performed according to the manufac-
turer’s protocol. Further data processing and identification of
differentially expressed genes were carried out in the R environ-
ment for statistical computing (R Development Core Team
2005) using the Bioconductor base installation (Gentleman et al.
2004) and packages affyPLM, gcrma, and limma. Briefly, array
quality was assessed with affyPLM, and data were normalized
with gcrma. Probe sets with low variance of expression across
all arrays were filtered out, and differentially expressed genes
were identified using the empirical Bayes-moderated t-test
implemented in the limma package. P-values associated with
the t-statistics were adjusted using a false-discovery-rate ap-
proach to compensate for multiple testing. Genes were consid-
ered differentially expressed if the difference of their expression
level had a p-value of 0.05.
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